The Use of J-Plasma® for Dermal Resurfacing

Exclusion Criteria

• •1. Subject with a Fitzpatrick Skin Scale score \>III.
• •2. Subject is pregnant or lactating.
• •3. Active HSV-1 or diabetes mellitus.
• •4. Active cut, wound, or infection on the skin of the face.
• •5. Subject has used, within the past 30 days, Accutane or any medication that can cause dermal hypersensitivity.
• •6. Subject has a history of autoimmune disease.
• •7. Subject with a bleeding disorder or who is on blood thinning medication that may be at risk for bleeding.
• •8. Subject has a known adverse reaction to anesthetics.
• •9. Subjects with active skin disease of the facial area or known connective tissue disease.
• •10. Subjects with known susceptibility to keloid formation or hypertrophic scarring.
• •11. Subjects with present cancerous or pre-cancerous lesions in the area to be treated.
• •12. Subject who, for any reason, suspects that they will not be able to complete the prescribed follow-up assessment(s);
• •13. Subject has had concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety and efficacy of the study treatment method.
• •14. Subject is not willing to release rights to study Sponsor for the use of the photos, including in potential publication.
• •15. Subject is enrolled in another investigational (drug or device) clinical trial that can interfere with this study's assessments.
• •16. Subject has undergone a facelift procedure or received facial injections within the past year.